Malignant Laryngeal Neoplasm — Trials

Malignant Laryngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

275 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 66
Recruiting: 41
Ph III recruiting: 5
Growth YoY: —
Industry share: 2%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.1%
Trials / 1,000 deaths: 16.9 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (40)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02177838	Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer	terminated	N/A	8	Rutgers, The State University of New JerseyOTHER	1	Apr 21, 2021	clinicaltrials
NCT02388932	Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer	terminated	N/A	3	Case Comprehensive Cancer CenterOTHER	1	Jan 24, 2019	clinicaltrials